Erbitux

Showing Topics 1 - 8 of 8. RSS Feed

 Erbitux Cetuximab

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Bristol-Myers Squibb and outside those countries by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb and Eli...
 Cetuximab

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Bristol-Myers Squibb and outside those countries by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb and Eli...
oncology / cancer drug

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies). Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. ...

Updated in Herceptin
Erbitux

I am about to start treatment for a HPV related tonsillar cancer and Erbitux is one of the drugs I will be treated with. The side effect profile looks pretty severe. What have you experienced? ...

Updated in Erbitux
 NDC 66733-948
Erbitux 2 mg/ml Intravenous Solution by Imclone LLC ## Package Codes: 66733-948-23 ## Active Ingredients: Cetuximab
 NDC 66733-958
Erbitux 2 mg/ml Intravenous Solution by Imclone LLC ## Package Codes: 66733-958-23 ## Active Ingredients: Cetuximab
 NDC 65044-7462
Erbitux 2 mg/ml Intravenous Solution by Jubilant Hollisterstier LLC ## Package Codes: 65044-7462-1 ## Active Ingredients: Cetuximab
 NDC 65044-7463
Erbitux 2 mg/ml Intravenous Solution by Jubilant Hollisterstier LLC ## Package Codes: 65044-7463-1 ## Active Ingredients: Cetuximab




Can't Find What You're Looking For? Submit a New Topic Below

No registration needed.
Simply fill out the form below.

 *
What are the main keywords of your topic?


 *

 *


 Optional, stays hidden.
Get notified when a reply is posted here.




5) Text Verification: *
Prevents SPAM.

Click here to show the question



This form will be submitted securely


TRUSTe

Discussion Thread Guidelines: Any participation in the discussion threads signifies your agreement with the Terms of Use and Privacy Policy. (1) Act civilized and be respectful towards others. No profanity, vulgarity or lewd / suggestive content is allowed. (2) Posts encouraging, facilitating, or seeking advice about the abuse of medications or other substances are prohibited. (3) Personal contact information (such as telephone numbers, email addresses, etc) is not allowed to appear on our discussion threads. (4) We do not allow our forums to be used for buying, selling, trading, or for the promotion of a product or service. (5) Posting external links to other web sites is not allowed without our prior approval. (6) We reserve the right to edit or remove content which we find objectionable to the community at our sole discretion.



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA